Nasal Spray Reduces COVID Severity
A pharmaceutical company in Vancouver, Canada called SaNOtize, has been developing topical antimicrobial products to help fight drug resistant infections, and recently, to fight SARS-CoV-2,
A pharmaceutical company in Vancouver, Canada called SaNOtize, has been developing topical antimicrobial products to help fight drug resistant infections, and recently, to fight SARS-CoV-2,
In this brief, we recommend that ivermectin should be considered as a suitable candidate for early out-patient treatment for COVID-19, as well as a prophylactic.
This TrialSite article discusses the Ivermectin petition initiated by a member the CCCA regarding Ivermectin.
Dr. Ira Bernstein recommends Vit D, advocates for early treatment, describes multi-drug use for late phase COVID-19, and comments on Ivermectin supply in Canada.
Dr. Harvey Risch discusses how lockdowns affect herd immunity, vaccines vs. early treatment, how to critically read a scientific paper, censorship and more.
Dr. HowardTenenbaum talks about early treatment drugs (including potentially Doxycyclene), how these are being ignored/dismissed & the need for senior academics to speak out.
Three physicians discuss international experiences for the outpatient management of COVID-19, recognizing it is biphasic and the treatment approach is dependent on the phase of
Dr. Linda Rapson, MD talks about building a healthy immune system using nutriceuticals to prevent disease.
Dr. David Chesler recounts the success he’s had treating nursing home patients with Ivermectin.
Dr. Darrell DelMello – One physician’s learning and treatment experience with COVID-19 over a year using anti-inflammatory, anti-viral, and anti-clotting medications for over 3000 patients
ENTER YOUR SEARCH TERMS AND HIT ENTER